I'm pretty sure that in NZ, advice from your GP (over the past few years) would be consistent with what the trial confirmed anyway.
But the enteric coated aspirin pills shaped like hearts are being marketed and available "off the shelf" with apparent suggested therapeutic benefit, people will self-medicate - when it seems more clear now - that many probably shouldn't. Medsafe could (IMO) look at that packaging, and perhaps change dispensing rules if they determine that's needed. IOW make it OTC dispensed by a pharmacist - rather than off the shelf.


